This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Veenstra DL, Sullivan SD, Dusheiko GM, Jacobs M, Aledort JE, Lewis G, Patel KK.Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom. European Journal of Gastroenterology and Hepatology 19: 631-638, No. 8, Aug 2007
Rights and permissions
About this article
Cite this article
Peginterferon-α-2a well worth it for chronic hepatitis B. Pharmacoecon. Outcomes News 535, 3 (2007). https://doi.org/10.2165/00151234-200705350-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705350-00006